
Please try another search
Health Canada authorized Moderna (NASDAQ:MRNA)'s updated COVID-19 mRNA vaccine, Spikevax, targeting the SARS-CoV-2 LP.8.1 variant for individuals aged six months and older, according to a company...
Investing.com-- U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday announced plans to cut about $500 million in funding for vaccine development projects using mRNA technology. Kennedy, a longtime...
Investing.com - Leerink Partners lowered its price target on Moderna (NASDAQ:MRNA) stock to $18.00 from $20.00 on Monday, while maintaining an Underperform rating following the company's recent...
Investing.com - BofA Securities has lowered its price target on Moderna (NASDAQ:MRNA) to $24.00 from $25.00 while maintaining an Underperform rating on the stock. The move comes as the stock has...
Investing.com - Moderna (NASDAQ:MRNA) shares fell approximately 7% intraday after UBS reiterated its Buy rating and $70.00 price target on the stock. The biotech company, currently valued at $10.8...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review